This company listing is no longer active
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
TCR2 Therapeutics 관리
관리 기준 확인 3/4
TCR2 Therapeutics' CEO is Garry Menzel, appointed in Jan 2016, they has a tenure of 6.67 years. Their total yearly compensation is $1.90M , comprised of 30.4% salary and 69.6% bonuses, including company stock and options. They directly owns 0.69% of the company’s shares, worth €656.23K. The average tenure of the management team and the board of directors is 2 years and 3.1 years respectively.
주요 정보
Garry Menzel
최고 경영자
US$1.9m
총 보상
| CEO 급여 비율 | 30.4% |
| CEO 임기 | 6.7yrs |
| CEO 소유권 | 0.7% |
| 경영진 평균 재임 기간 | 2yrs |
| 이사회 평균 재임 기간 | 3.1yrs |
최근 관리 업데이트
Recent updates
CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$115m |
| Mar 31 2022 | n/a | n/a | -US$107m |
| Dec 31 2021 | US$2m | US$580k | -US$100m |
| Sep 30 2021 | n/a | n/a | -US$91m |
| Jun 30 2021 | n/a | n/a | -US$81m |
| Mar 31 2021 | n/a | n/a | -US$73m |
| Dec 31 2020 | US$6m | US$560k | -US$67m |
| Sep 30 2020 | n/a | n/a | -US$61m |
| Jun 30 2020 | n/a | n/a | -US$58m |
| Mar 31 2020 | n/a | n/a | -US$53m |
| Dec 31 2019 | US$8m | US$492k | -US$97m |
| Sep 30 2019 | n/a | n/a | -US$96m |
| Jun 30 2019 | n/a | n/a | -US$100m |
| Mar 31 2019 | n/a | n/a | -US$107m |
| Dec 31 2018 | US$3m | US$436k | -US$62m |
| Sep 30 2018 | n/a | n/a | -US$55m |
| Dec 31 2017 | US$792k | US$423k | -US$15m |
보상 대 시장: Garry's total compensation ($USD1.90M) is above average for companies of similar size in the German market ($USD410.59K).
보상과 수익: Garry's compensation has been consistent with company performance over the past year.
CEO
Garry Menzel (58 yo)
6.7yrs
테뉴어
US$1,904,534
보상
Dr. Garry E. Menzel, Ph D., M.B.A. serves as an Independent Director at Black Diamond Therapeutics, Inc. since March 2017. He serves as Director at Stoke Therapeutics, Inc since August 17, 2020.He serves...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 6.7yrs | US$1.90m | 0.69% € 656.2k | |
| Founder & Member of the Advisory Board | no data | US$47.02k | 데이터 없음 | |
| Chief Technical Officer | 1.2yrs | US$2.74m | 0.0057% € 5.4k | |
| Chief Medical Officer | 5.7yrs | US$1.04m | 0.12% € 116.0k | |
| Vice President of Corporate Controller | less than a year | 데이터 없음 | 데이터 없음 | |
| Chief Financial Officer | less than a year | 데이터 없음 | 데이터 없음 | |
| Senior Director of Investor Relations & Corporate Communications | no data | 데이터 없음 | 데이터 없음 | |
| Head of Legal & Corporate Secretary | 4.7yrs | 데이터 없음 | 데이터 없음 | |
| Chief People Officer | 2.9yrs | 데이터 없음 | 0.025% € 24.0k | |
| Chief Business & Strategy Officer | less than a year | 데이터 없음 | 데이터 없음 |
2.0yrs
평균 재임 기간
48yo
평균 연령
경험이 풍부한 관리: 2K7's management team is considered experienced (2 years average tenure).
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 6.7yrs | US$1.90m | 0.69% € 656.2k | |
| Founder & Member of the Advisory Board | less than a year | US$47.02k | 데이터 없음 | |
| Independent Director | 7.3yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 4.6yrs | US$92.52k | 0% € 0 | |
| Chairman of Advisory Board | no data | US$18.75k | 데이터 없음 | |
| Independent Chairman of the Board | 2.3yrs | US$89.08k | 0% € 0 | |
| Independent Director | 3.8yrs | US$86.58k | 0% € 0 | |
| Independent Director | 2.4yrs | US$78.08k | 0% € 0 | |
| Independent Director | 1.6yrs | US$405.41k | 0% € 0 | |
| Member of Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of the Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Advisory Board | no data | 데이터 없음 | 데이터 없음 |
3.1yrs
평균 재임 기간
63yo
평균 연령
경험이 풍부한 이사회: 2K7's board of directors are considered experienced (3.1 years average tenure).